Mast Cell Tumors Treatment Market with COVID-19 Impact Analysis, By Drug Class (Antihistamines, Epinephrine, Steroids, Mast-cell stabilizers), By Route of Administration (Oral, Injectables, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Mast Cell Tumors Treatment Market size was valued at USD 5,100 Million in 2022, expanding at a CAGR of 3.6% from 2023 to 2030.
Mast cell tumors (MCTs) are a kind of cancer that is frequent in dogs. Mast cells, a kind of immune cell implicated in allergic responses and inflammation, are the source of these tumors. MCTs come in a variety of sizes, shapes, and malignancies. Mast cell tumors are normally treated surgically, with the goal of entirely excising the tumor. Additional treatments, such as radiation, chemotherapy, or targeted drugs, may be required in certain circumstances, particularly for aggressive or metastatic tumors. Regular veterinarian check-ups and monitoring are essential for dogs at risk of MCTs since early discovery and timely treatment are critical for a favorable outcome.
Mast Cell Tumors Treatment Market- Market Dynamics
- Increasing emphasis on precision medicine in veterinary oncology propel market demand
Targeted therapy becomes increasingly possible as knowledge of the genetic and molecular mechanisms that contribute to MCT genesis and progression improves. This personalized method tailor’s medicines to the tumor\'s individual features, maximizing effectiveness while minimizing negative effects. The development of innovative targeted medications and immunotherapies is gaining traction, led by genetic and molecular analysis of individual tumours. This driver improves not just treatment results but also the entire quality of life for dogs suffering from MCTs and other malignancies.
Mast Cell Tumors Treatment Market- Key Insights
- As per the analysis shared by our research analyst, the global Mast Cell Tumors Treatment market is estimated to grow annually at a CAGR of around 3.6% over the forecast period (2023-2030)
- The Mast Cell Tumors Treatment industry is projected to grow at a significant rate due to increasing emphasis on precision medicine in veterinary oncology.
- Based on Drug Class segmentation, Epinephrine was predicted to show maximum market share in the year 2022
- Based on Route of Administration segmentation, Injectables was the leading Drug Class in 2022
- On the basis of region, Asia Pacific was the leading revenue generator in 2022
Mast Cell Tumors Treatment Market- Segmentation Analysis:
The Global Mast Cell Tumors Treatment Market is segmented on the basis of Drug Class, Route of Administration, Distribution Channel, and Region.
The market is divided into four categories based on Drug Class: Antihistamines, Epinephrine, Steroids, Mast-cell stabilizers. The Epinephrine dominates the market. Because MCTs have the ability to produce histamines, which may cause severe allergic responses in certain circumstances, epinephrine need may occur during therapy. As an emergency medication, epinephrine aids in the management of anaphylactic responses caused by MCT degranulation, allowing for faster intervention and better patient outcomes.
The market is divided into three categories based on Route of Administration: Oral, Injectables, Topical. The Injectables sector dominates the market and is likely to maintain its dominance during the forecast period. Injectable medicines are in high demand for the treatment of mast cell tumors for a variety of reasons. They are used to deliver chemotherapy, targeted treatments, and emergency medications like as epinephrine in situations of severe allergic responses induced by MCT degranulation, providing successful and speedy treatment of this difficult type of cancer.
Mast Cell Tumors Treatment Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Mast cell tumors (MCTs) in dogs are becoming more popular in the Asia-Pacific area. This tendency is influenced by a variety of things. Increased pet ownership rates in several nations around the area have resulted in a burgeoning market for veterinarian services and treatments. Second, increased knowledge of canine health issues, particularly cancers such as MCTs, has prompted more pet owners to seek medical attention for their pets. Finally, advances in veterinary oncology and an increasing number of specialized veterinary clinics and hospitals in the Asia-Pacific area have enhanced access to diagnostic and treatment choices, satisfying the region\'s growing need for effective MCT treatments.
Mast Cell Tumors Treatment Market- Competitive Landscape:
The therapy landscape for mast cell tumors (MCTs) is dynamic, with various elements at work. Chemotherapy and targeted medicines are available from leading veterinary pharmaceutical firms such as Zoetis, Elanco, and Merck Animal Health. Furthermore, sophisticated radiation therapy are available at specialized veterinary cancer centers such as PetCure cancer. Research and development initiatives targeted at developing novel medicines can have an impact on the environment. Collaboration among pharmaceutical firms, research institutions, and veterinary clinics promotes MCT therapy advancement. With a rising focus on pet healthcare, competition promotes therapeutic improvements, eventually helping canine MCT sufferers and their families.
Recent Developments:
- In May 2023, Sensus Healthcare Inc., a leading provider of sophisticated medical devices for non-surgical skin cancer and keloid scar treatment, is pleased to announce that their superficial radiation therapy SRT-100 system has shown encouraging results in treating Cutaneous Mast Cell Tumours (MCTs) in cats. This new restricted research, which recently appeared in the Journal of the American Veterinary Medical Association, shows the potential efficacy and safety of SRT therapy.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MAST CELL TUMORS TREATMENT MARKET KEY PLAYERS
- Zoetis
- Elanco Animal Health
- Merck Animal Health
- Boehringer Ingelheim
- PetCure Oncology
- Varian Medical Systems
- VetDC, Inc.
- Oasmia Pharmaceutical AB
- Aratana Therapeutics
- Rhizen Pharmaceuticals
- Animal Medical Center
- Blue Buffalo Foundation
- Ethos Veterinary Health
- PetCure Oncology
- Veterinary Cancer Group
GLOBAL MAST CELL TUMORS TREATMENT MARKET, BY DRUG CLASS
- Antihistamines
- Epinephrine
- Steroids
- Mast-cell stabilizers
GLOBAL MAST CELL TUMORS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION
- Oral
- Injectables
- Topical
GLOBAL MAST CELL TUMORS TREATMENT MARKET, BY DISTRIBUTION CHANNEL
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
GLOBAL MAST CELL TUMORS TREATMENT MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
Rest of MEA
TABLE OF CONTENT
1. Mast Cell Tumors Treatment Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Mast Cell Tumors Treatment Market Snippet by Drug Class
2.1.2. Mast Cell Tumors Treatment Market Snippet by Route of Administration
2.1.3. Mast Cell Tumors Treatment Market Snippet by Distribution Channel
2.1.4. Mast Cell Tumors Treatment Market Snippet by Country
2.1.5. Mast Cell Tumors Treatment Market Snippet by Region
2.2. Competitive Insights
3. Mast Cell Tumors Treatment Key Market Trends
3.1. Mast Cell Tumors Treatment Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Mast Cell Tumors Treatment Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Mast Cell Tumors Treatment Market Opportunities
3.4. Mast Cell Tumors Treatment Market Future Trends
4. Mast Cell Tumors Treatment Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Mast Cell Tumors Treatment Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Mast Cell Tumors Treatment Market Landscape
6.1. Mast Cell Tumors Treatment Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Mast Cell Tumors Treatment Market – By Drug Class
7.1. Overview
7.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
7.1.2. Antihistamines
7.1.3. Epinephrine
7.1.4. Steroids
7.1.5. Mast-cell stabilizers
8. Mast Cell Tumors Treatment Market – By Route of Administration
8.1. Overview
8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
8.1.2. Oral
8.1.3. Injectables
8.1.4. Topical
9. Mast Cell Tumors Treatment Market – By Distribution Channel
9.1. Overview
9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
9.1.2. Hospital Pharmacies
9.1.3. Retail Pharmacies
9.1.4. Drug Stores
9.1.5. Online Pharmacies
10. Mast Cell Tumors Treatment Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Mast Cell Tumors Treatment Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Mast Cell Tumors Treatment Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Mast Cell Tumors Treatment Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Mast Cell Tumors Treatment Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Mast Cell Tumors Treatment Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Mast Cell Tumors Treatment Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Zoetis
11.2.2. Elanco Animal Health
11.2.3. Merck Animal Health
11.2.4. Boehringer Ingelheim
11.2.5. PetCure Oncology
11.2.6. Varian Medical Systems
11.2.7. VetDC, Inc.
11.2.8. Oasmia Pharmaceutical AB
11.2.9. Aratana Therapeutics
11.2.10. Rhizen Pharmaceuticals
11.2.11. Animal Medical Center
11.2.12. Blue Buffalo Foundation
11.2.13. Ethos Veterinary Health
11.2.14. PetCure Oncology
11.2.15. Veterinary Cancer Group
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
